Aurelio Maggio: How Is The Treatment Landscape Of Thrombotic Thrombocytopenic Purpura Evolving?
Aurelio Maggio, President of Franco and Piera Cutino Foundation, shared a post on LinkedIn:
“How is the treatment landscape of thrombotic thrombocytopenic purpura (TTP) evolving?
In this new GARDEN Experts Insights article, Prof. Raimondo De Cristofaro discusses current therapeutic strategies, remaining clinical challenges, and future perspectives in the management of TTP.
A valuable expert contribution on one of the most severe rare hematological disorders.”
Global Hematological Rare Diseases Alliance (GARDEN) shared a post on LinkedIn:
“What are the key challenges and opportunities in the treatment of thrombotic thrombocytopenic purpura (TTP)?
In this new contribution from the GARDEN Experts Insights series, Prof. Raimondo De Cristofaro shares his perspective on the evolving landscape of TTP management, discussing current therapeutic approaches, unresolved clinical challenges, and emerging strategies that may further improve patient outcomes.
A valuable expert insight into one of the most complex and potentially life-threatening rare hematological disorders.”
Stay updated with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: A Few Minutes of Giving Can Mean a Lifetime
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion